Toronto – March 29, 2023 – The Canadian Nuclear Isotope Council (CNIC) launched its new Isotopes for Hope campaign at the Empire Club of Canada with the goal of asserting and expanding Canada’s Global leadership isotope in the development, supply
Toronto – February 24, 2023 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce its recent accomplishment in achieving Not-for-Profit status. In collaboration with the CNIC’s new Board of Directors, the CNIC has worked diligently over the last
Toronto – February 7, 2023 – ACIC Pharmaceutical Machinery, a Canadian company located in Brantford, ON, is the newest member of the Canadian Nuclear Isotope Council (CNIC). ACIC Machinery provides complete equipment and automation solutions needed to manufacture radiopharmaceuticals. Together,
Toronto – December 20, 2022 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce a partnership with ARC Clean Technology (ARC). As a member of the CNIC, ARC joins 76+ organizations and companies in Canada’s isotope community that
Toronto – November 10, 2022 – There is mounting concern in Canada and around the world that a global medical isotope shortage of Molybdenum-99 (Mo-99) is impacting patients. As a result, doctors will have to start rescheduling patients in need
Toronto – November 2, 2022 – AtomVie Global Radiopharma Inc. (AtomVie), a manufacturer and supplier of multiple finished-dose therapeutic radiopharmaceutical products, is the newest member of the Canadian Nuclear Isotope Council (CNIC). AtomVie has developed over 7 years of experience
Toronto, Ontario – October 25, 2022 – Yesterday, the international partnership between Bruce Power, Isogen (a Kinectrics and Framatome company), and ITM Isotope Technologies Munich (ITM), announced the start of commercial production of lutetium-177. Lutetium-177 is a medical isotope used
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes (OTTAWA, ON – September 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. has submitted a new drug application to the
Toronto – August 16, 2022 – The Canadian Nuclear Isotope Council (CNIC) is proud to participate in a joint Industry Statement to the Tenth Review Conference of the Parties to the Treaty on the Non-Proliferation of Nuclear Weapons (NPT) alongside
(OTTAWA, ON – June 13, 2022) – BWX Technologies, Inc. (NYSE: BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production
THIS POSITION IS NOW FILLED Job Overview Policy, Government and Stakeholder Relations Specialist at the CNIC is responsible for connecting federal, provincial, and municipal political leaders to the organization and the broader Canadian Isotope Ecosystem. Reporting to the Executive Director,
Helium-3 (He-3) is a rare isotope used in research, border security and medical imaging In a world where raw materials and supplies are under tension, Helium-3 (He-3), a rare isotope used in quantum computing, neutron research, border security and medical